The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

Flies circulating in hospital wards may pose a threat to vulnerable patients by spreading bacteria that are resistant to ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic ...

The world’s first vaccine for mosquito-borne chikungunya virus has been approved by the UK’s Medicines and Healthcare ...

At least five suspected cases of chikungunya were recorded in Davao City in January 2025. The residents who were suspected of ...